Compare BLTE & IFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLTE | IFS |
|---|---|---|
| Founded | 2018 | 1897 |
| Country | United States | Peru |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.6B |
| IPO Year | 2021 | 2014 |
| Metric | BLTE | IFS |
|---|---|---|
| Price | $129.67 | $47.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $233.00 | $65.23 |
| AVG Volume (30 Days) | 142.0K | ★ 193.7K |
| Earning Date | 11-12-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 3.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $26.33 |
| Revenue Next Year | N/A | $6.14 |
| P/E Ratio | ★ N/A | $9.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $115.41 | $39.51 |
| 52 Week High | $200.00 | $61.38 |
| Indicator | BLTE | IFS |
|---|---|---|
| Relative Strength Index (RSI) | 32.18 | 38.00 |
| Support Level | N/A | $46.49 |
| Resistance Level | $158.76 | $51.89 |
| Average True Range (ATR) | 9.11 | 1.69 |
| MACD | -1.46 | 0.08 |
| Stochastic Oscillator | 19.04 | 19.47 |
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services, and payments for retail customers and commercial clients in Peru. Its purpose is centered around building financial well-being together. The company has three operating business segments: Banking, mainly loans, credit facilities, deposits, and current accounts; Insurance provides life annuity products with single-premium payment and conventional life insurance products, as well as other retail insurance products; and Wealth management provides brokerage and investment management services. Inteligo serves mainly Peruvian citizens.